David S. Siegel, MD, PhD

David S. Siegel, MD, PhD

Episodes

Specialty:

All

Year:

All

EP. 1: Treatment Approaches in Newly Diagnosed Multiple Myeloma

July 17th 2015

EP. 2: High-Risk Versus Low-Risk Multiple Myeloma

July 17th 2015

EP. 3: Multiple Myeloma: Considerations in Stem Cell Transplantation

July 17th 2015

EP. 4: Resistance to Multiple Myeloma Maintenance Therapy

July 17th 2015

EP. 5: Panobinostat in Relapsed/Refractory Multiple Myeloma

July 17th 2015

EP. 6: Pomalidomide and Carfilzomib in Refractory Multiple Myeloma

July 17th 2015

EP. 7: Role of Carfilzomib in Multiple Myeloma

July 17th 2015

EP. 8: Monoclonal Antibodies in Multiple Myeloma

July 17th 2015

EP. 9: Immunomodulatory Agents in Multiple Myeloma

July 17th 2015

Trending on OncLive

Five Under 5: Top Oncology Videos for the Week of 8/31/26

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer

The OncFive: Top Oncology Articles for the Week of 8/30

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC